| Q31060674 | A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data. |
| Q34584310 | A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling |
| Q45104833 | An empirical examination of respondent driven sampling design effects among HIV risk groups from studies conducted around the world. |
| Q35207130 | Epidemiology of hepatitis C viral infection in Faisalabad, Pakistan: a retrospective study (2010-2012) |
| Q30986227 | Estimating the Size of Hidden Populations Using Respondent-driven Sampling Data: Case Examples from Morocco |
| Q64102818 | Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis |
| Q38176136 | Estimating the size of key populations: current status and future possibilities. |
| Q37108808 | Global risk assessment of aflatoxins in maize and peanuts: are regulatory standards adequately protective? |
| Q35155240 | HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling |
| Q36652189 | HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China |
| Q99205600 | Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017) |
| Q33893260 | Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling |
| Q53688262 | Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities. |
| Q37846011 | Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria |
| Q30239061 | Theoretical and Empirical Comparisons of Methods to Estimate the Size of Hard-to-Reach Populations: A Systematic Review |
| Q42661491 | Unexpectedly high injection drug use, HIV and hepatitis C prevalence among female sex workers in the Republic of Mauritius |
| Q46000139 | Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia. |